GSK: Life-saving products with sustainability issues – An alva Case Study
The Emerging Threat: Balancing life-saving products with planet-polluting ingredients.
GSK, and indeed the pharmaceutical sector, has an emerging reputational challenge – manufacturing products designed to make it easier for people to breathe, but doing so with planet-polluting ingredients. Environmental sustainability Initiatives being used by GSK’s sector peers to promote their ESG credentials – and so reduce reputational risk – offer some inspiration to counter the threat. Pfizer, Novartis, Johnson & Johnson, Novo Nordisk, and AstraZeneca UK have all launched initiatives such as net zero targets, renewable electricity targets, recycling schemes and tree planting programmes.
If you want to follow reading, you can download “GSK: Live-saving products with sustainability issues” Case Study.
Register below to receive alva’s "GSK: Life-saving products with sustainability issues" Case Study: